Dr. Muna Qayed, MD, MS
Claim this profileChildren's Healthcare of Atlanta
Area of expertise
Acute Lymphoblastic Leukemia
Muna Qayed, MD, MS has run 5 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Bone Marrow Transplant
Muna Qayed, MD, MS has run 3 trials for Bone Marrow Transplant. Some of their research focus areas include:
Affiliated Hospitals
Children's Healthcare Of Atlanta
Children's Healthcare Of Atlanta SC CTL019
Clinical Trials Muna Qayed, MD, MS is currently running
Virtual Rehabilitation
for Post Bone Marrow Transplant Recovery
Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL). Physical activity and exercise have been shown to enhance fitness and improve QoL in chronic illnesses including GVHD, however, patients often have barriers to attending sessions including distance, risk of infection, and physical therapists' lack of experience with pediatric patients. The team's goal is to assess whether a virtual rehabilitation program in children post-HCT (including children with chronic GVHD) is feasible and whether its implementation will improve physical functioning and QoL. Patients between the ages of 8 and 23 years who are at least one hundred days post-HCT will be eligible for participation. Patients will have an assessment by a pediatric physical therapist at the time of study entry, at the end of the rehabilitation program, and approximately 3 months later. They will be supplied with some exercise equipment (such as dumbbells and resistance bands). Patients will have twice weekly half-hour one-on-one online sessions with the physical therapist for 12 weeks. Patients will be recruited through the bone marrow transplant clinic.
Recruiting
1 award
N/A
Non-TBI Conditioning
for HCT in Acute Lymphoblastic Leukemia
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regimen as part of the treatment cohort of the study. Subjects who are pre-HCT NGS-MRD positive will be treated as per treating center standard and will be followed in an observational cohort (HCT center standard of care).
Recruiting
1 award
Phase 2
More about Muna Qayed, MD, MS
Clinical Trial Related
2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Muna Qayed, MD, MS has experience with
- Fludarabine
- Cyclophosphamide
- Prednisone
- Donor Search Prognosis Score
- NGS-MRD
- Myeloablative Allogeneic HCT With A Non-TBI Conditioning Regimen
Breakdown of trials Muna Qayed, MD, MS has run
Acute Lymphoblastic Leukemia
Bone Marrow Transplant
Lymphoma
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Muna Qayed, MD, MS specialize in?
Muna Qayed, MD, MS focuses on Acute Lymphoblastic Leukemia and Bone Marrow Transplant. In particular, much of their work with Acute Lymphoblastic Leukemia has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Muna Qayed, MD, MS currently recruiting for clinical trials?
Yes, Muna Qayed, MD, MS is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Muna Qayed, MD, MS has studied deeply?
Yes, Muna Qayed, MD, MS has studied treatments such as Fludarabine, Cyclophosphamide, Prednisone.
What is the best way to schedule an appointment with Muna Qayed, MD, MS?
Apply for one of the trials that Muna Qayed, MD, MS is conducting.
What is the office address of Muna Qayed, MD, MS?
The office of Muna Qayed, MD, MS is located at: Children's Healthcare of Atlanta, Atlanta, Georgia 30322 United States. This is the address for their practice at the Children's Healthcare of Atlanta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.